Threshold Pharma Pops 18% on Positive Quarterly Results

Shares of Threshold Pharma THLD are seeing much strength during Thursday's trading session after the company announced fourth quarter results which were better than analyst expectations. The net loss for the fourth quarter and year ended December 31, 2011 was $5.3 million and $25.7 million, respectively. As of December 31, 2011, Threshold had $20.3 million in cash, cash equivalents and marketable securities, with no debt outstanding. The net loss for 2011 was $25.7 million compared to a net loss of $18.7 million in 2010. Included in the net loss for 2011 was non-cash income of $4.4 million compared to non-cash income of $5.2 million in 2010. The non-cash income related to the changes in fair value of the Company's outstanding warrants and was classified as other income (expense). Total research and development expenses for 2011 increased to $24.4 million from $18.9 million in 2010. Currently, shares of Threshold Pharma are trading up about 18% at $5.60 per share.